Tufan EGELİ, Mesut AKARSU, Anıl AYSAL, Mücahit ÖZBİLGİN, Tarkan UNEK, Cihan AĞALAR, İbrahim ASTARCIOĞLU, Özgül SAĞOL, Ziya AYHAN

Liver transplantation in Wilson’s disease: Long-term experience of single center

Aim: Liver transplantation (LT) is the most effective treatment method for preventing progressive and lethal complications of Wilson’sdisease (WD). Despite the deceased donor liver transplantation (DDLT) and living donor liver transplantation (LDLT) are performedin many centers for WD, a limited number of reports were published, about long-term results. The aim of this study is to share thelong-term outcomes of single center.Material and Methods: Patients who underwent LT for the WD, between 1997 and 2017 were included. Patient’s survival data, deathcauses, neurological symptoms and follow-up data were analyzed retrospectively.Results: Eighteen patients (8DDLT, 10LDLT) with the median age of 17.11±9.88 (6-43) were included. Donor relationship was familialin all LDLT patients. Median follow-up time was 80.57±67.59 (0.23-240.9) months and the median survival time was 173.74±25.13months. Two patients (11.1%) died in the perioperative period (0-90 days) and totally 3 patients (16.6%) died in the postoperative0-12 month’s period. The survival rates of the patient’s at 1-, 5- and 10 years were 83.3%, 75% and 67.3%, respectively. After LT,neurological symptoms disappeared in 6 of 7 patients and no improvement was observed in one patient. During follow-up period,chronic rejection was seen in 5 patients, 3 patients were treated with medical procedure and 2 patients died due to chronic rejection.Conclusions: Our findings are consistent with the literature, long-term survival is achieved in patients with no mortality, in thepostoperative 0-12 month period and after LT, neurological symptoms are disappeared in most of the patients; according to thisdata, LT is an effective treatment method for the WD and complications.

PDF

___

1. Pabón V, Dumortier J, Gincul R, et al. Long-term results of liver transplantation for Wilson’s disease. Gastroenterol. Clin. Biol 2008;32:378-81.
2. Catana AM, Medici V. Liver transplantation for Wilson disease. World J. Hepatol 2012;4:5-10.
3. Haberal M, Moray G, Karakayali H, et al. Liver Transplantation for Wilson ’ s Cirrhosis : One Center ’ s Experience. Transpl. Proc 1999;31:3160-1.
4. Lin L-J, Wang D-X, Ding NN, et al. Comprehensive analysis on clinical features of Wilson’s disease: an experience over 28 years with 133 cases. Neurol. Res 2014;36:157-63.
5. Ferenci P, Czlonkowska A, Stremmel W, et.al. EASL clinical practice guidelines: wilson’s disease. J. Hepatol 2012;56:671-85.
6. Steindl P, Ferenci P, Dienes HP, et al. Wilson’s disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterol 1997;113:212-18.
7. Lorincz MT. Neurologic Wilson’s disease. Ann. N Y. Acad. Sci 2010;1184:173-87.
8. Pfister ED, Karch A, Polak WG, et sl. Predictive factors for survival in children liver transplanted for Wilson disease: a cohort study using ELTR data. Liver Transplant 2018.
9. Medici V, Mirante VG, Fassati LR, et al. Liver transplantation for Wilson’s disease: The burden of neurological and psychiatric disorders. Liver Transplant 2005;11:1056-63.
10. Stracciari A, Tempestini A, Borghi A, et al. Effect of liver transplantation on neurological manifestations in Wilson disease. Arch Neurol 2000;57:384–86.
11. Eghtesad B, Nezakatgoo N, Geraci LC, et al. Liver transplantation for Wilson’s disease: a single-center experience. Liver Transpl Surg 1999;5:467-74.
12. Yagci MA, Tardu A, Karagul S, et al. Influence of Liver Transplantation on Neuropsychiatric Manifestations of Wilson Disease. Transplant. Proc. 2015;47:1469-73.
13. Członkowska A, Tarnacka B, Möller JC, et al. Unified wilson’s disease rating scale - a proposal for the neurological scoring of wilson’s disease patients. Neurol Neurochir Pol 2007;41:1-12.
14. Erol I, Alehan F, Ozcay F, et al. Neurologic complications of liver transplantation in pediatric patients with the hepatic form of wilson’s disease. J. Child Neurol 2008;23:293-300.
15. Öcal R, Öcal S, Kırnap M, et al. Complications of liver transplant in adult patients with the hepatic form of wilson disease. Exp Clin Transplant 2018;16:38-40.
16. Arnon R, Annunziato R, Schilsky M, et al. Liver transplantation for children with Wilson disease: Comparison of outcomes between children and adults. Clin. Transplant 2011;25:52- 60.
17. Haberal M, Akdur A, Moray G, et al. Auxiliary partial orthotopic living liver transplant for wilson disease. Exp Clin Transplant 2017;15:182-84.
18. Ozcay F, Us B, Baskin E, et al. Long term follow-up of glomerular and tubular functions in liver transplanted patients with Wilson’ s disease. Pediatr Transplant 2008;12:785-89.
19. Rodriguez-Castro KI, Hevia-Urrutia FJ, Sturniolo GC. Wilson’s disease: A review of what we have learned. World J. Hepatol 2015;7:2859-870.
20. Cheng F, Li GQ, Zhang F, et al. Outcomes of living-related liver transplantation for Wilson’s disease: a single-center experience in China. Transplant 2009;87:751-57.
21. Yoshitoshi EY, Takada Y, Oike F, et al. Long-term outcomes for 32 cases of Wilson’s disease after living-donor liver transplantation. Transplant 2009;87:261-67.
22. Sevmis S, Karakayali H, Aliosmanoglu I, A, et al. Liver Transplantation for Wilson’s Disease. Transplant. Proc 2008;40:228-30.
23. Savas N, Canan O, Ozcay F, et al. Hepatocellular carcinoma in Wilson ’ s disease : A rare association in childhood. Pediatr Transplant 2006;10:639-43.
24. Reyes CV. Hepatocellular Carcinoma in Wilson Disease –related Liver Cirrhosis. Gastroenterol Hepatol (NY) 2008;4:435-37.
25. Lankarani KB, Malek-Hosseini SA, Nikeghbalian S, et al. Fourteen years of experience of liver transplantation for Wilson’s disease; A report on 107 cases from Shiraz, Iran. PLoS One 2016;11:1-11.
26. Guillaud O, Dumortier J, Sobesky R, et al. Long term results of liver transplantation for Wilson’s disease: Experience in France. J. Hepatol 2014;60:579-89.